76.11USD-1.08%Mkt Cap: 10.40B USDP/E: —Last update: 2026-05-26
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the Unit…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap10.40B USD
Enterprise Value10.34B USD
Revenue (TTM)105.81M USD
Gross Profit-327.99M USD
Net Income (TTM)-784.96M USD
Revenue/Share0.8720 USD
Last Price76.11 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees673
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.42
PEG—
EV/EBITDA-16.43
EV/Revenue97.70
P/S100.16
P/B-11.73
EPS (TTM)-6.85
EPS (Forward)-4.75
52W Range
29.8192% of range80.20
52W High80.20 USD
52W Low29.81 USD
Profitability
Gross Margin-372.55%
Oper. Margin-948.69%
EBITDA Margin0.00%
Profit Margin-891.60%
ROE119.00%
ROA-55.10%
Growth
Revenue Growth1125.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-510.01M USD
CapEx (TTM)24.81M USD
FCF Margin-360.12%
FCF Yield-3.66%
Net Debt625.07M USD
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity-1.95
Current Ratio4.21
Quick Ratio4.14
Book Value/Sh-6.6530 USD
Cash/Share6.578 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJun 25, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)104.70 USD
Target Range69.00 USD – 146.00 USD
# Analysts20
Ownership
Shares Out.135.77M
Float123.93M
Insiders0.70%
Institutions118.64%
Short Interest
Short Ratio9.3d
Short % Float20.84%
Short % Out.12.80%
Shares Short15.90M
Short (prev mo.)15.85M
Technical
SMA 5067.09 (+13.4%)
SMA 20060.33 (+26.2%)
Beta0.38
S&P 52W Chg28.31%
Avg Vol (30d)2.92M
Avg Vol (10d)2.83M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—